Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Single-Cell Omics Market Expected to Be in 2029?

The market size of single-cell omics has experienced a swift expansion in the past few years. It is projected to escalate from $2.08 billion in 2024 to $2.39 billion in 2025, achieving a compound annual growth rate (CAGR) of 14.9%. The substantial growth during the historical period was driven by factors such as the discovery of cellular heterogeneity, the development of single-cell analysis tools, advancements in biomedical research, characterizing the immune system, and the emergence of precision medicine.

The market size for single-cell omics is projected to experience swift expansion in the coming years, ballooning to “$4.45 billion in 2029 with a compound annual growth rate (CAGR) of 16.8%. This expansion during the forecast period can be linked to its clinical adoption and diagnostics, its integration with multi-omics approaches, its application in regenerative medicine, pharmaceutical development and discovery, cellular treatments and immunotherapies. Key trends forecasted in this period include single-cell in vivo studies, single-cell omics investigations related to infectious diseases, microfluidics and single-cell sorting, integration of single-cell multi-omics, and spatial profiling of single cells.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

What Are The Contributors To Demand In The Single-Cell Omics Market?

The mounting occurrence of cancer is projected to drive the ascent of the single-cell omics market in the foreseeable future. Cancer constitutes a range of diseases that can materialize in virtually any organ or tissue when deviant cells expand uncontrollably, breach their traditional boundaries, and spread to other organs or encroach upon surrounding body parts. The practice of discerning biomarkers for diagnosing cancer, forecasting prognosis, and unveiling new therapeutic objectives in pre-established clinical groups has significantly capitalized on single-cell omics data. For example, in May 2024, the National Institutes of Health, a governmental body in the US, reported that as of January 2022, nearly 18.1 million Americans were living as survivors of cancer. This figure is predicted to escalate to 22.5 million by 2032. As such, the escalating frequency of cancer is promoting the advancement of the single-cell omics market.

The single-cell omics market covered in this report is segmented –

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing

3) By Application: Oncology, Cell Biology, Neurology, Immunology

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits

2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits

3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits

4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

What Long-Term Trends Are Likely To Affect The Single-Cell Omics Market?

The rising trend of product innovation is making a significant impact in the single-cell omics market. Major players in this market are introducing innovative products to maintain their market dominance. An illustration of this is the May 2023 launch of the REM-I Platform by Deepcell, a US-based firm that provides software for single-cell dimensional morphology analysis. This scalable single-cell imaging, high-dimensional analysis, and cell sorting platform offer previously unachievable insights into cell biology. The REM-I Platform is expected to inspire new methods of discovery in multiple areas, such as cancer biology, developmental biology, stem cell biology, gene therapy, and functional screening, among others, by consolidating single-cell imaging, sorting, and high-dimensional analysis.

Who Are The Top-Ranked Companies In The Single-Cell Omics Market Today?

Major companies operating in the single-cell omics market include Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

How Is Single-Cell Omics Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the single-cell omics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12379&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model